Clinical features | Combination | |||||
---|---|---|---|---|---|---|
TA6/6 −3156GG, 211GG | TA6/6, −3156GG, 211GA | TA6/7, −3156GA, 211GG | TA6/7, −3156GA, 211GA | TA6/6, −3156GG, 211AA | TA7/7, −3156AA, 211GG | |
Gender | ||||||
 Male | 39 (51.3) | 21 (27.6) | 8 (10.5) | 2 (2.6) | 4 (5.3) | 2 (2.6) |
 Female | 8 (36.4) | 9 (40.9) | 5 (22.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
χ 2, P | 7.516, 0.185 | |||||
Age | ||||||
  < 57 years | 19 (46.3) | 13 (31.7) | 7 (17.1) | 1 (2.4) | 1 (2.4) | 0 (0.0) |
  > 57 years | 28 (49.1) | 17 (29.8) | 6 (10.5) | 1 (1.8) | 3 (5.3) | 2 (3.5) |
χ 2, P | 3.541, 0.617 | |||||
Family history | ||||||
 Yes | 1 (20.0) | 2 (40.0) | 1 (20.0) | 0 (0.0) | 1 (20.0) | 0 (0.0) |
 No | 46 (49.5) | 28 (30.1) | 12 (12.9) | 2 (2.2) | 3 (3.2) | 2 (2.2) |
χ 2, P | 3.571, 0.613 | |||||
Alcohol history | ||||||
 Yes | 18 (56.3) | 9 (28.1) | 3 (9.4) | 0 (0.0) | 2 (6.3) | 0 (0.0) |
 No | 29 (43.9) | 21 (31.8) | 10 (15.2) | 2 (3.0) | 2 (3.0) | 2 (3.0) |
χ 2, P | 7.516, 0.185 | |||||
Histological type | ||||||
 Tubular adenocarcinoma | 40 (53.3) | 18 (24.0) | 12 (16.0) | 1 (1.3) | 2 (2.7) | 2 (2.7) |
 Non-tubular adenocarcinoma | 7 (30.4) | 12 (52.2) | 1 (4.3) | 1 (4.3) | 2 (8.7) | 0 (0.0) |
χ 2, P | 11.488, 0.043 | |||||
Differentiation | ||||||
 Undifferentiated | 5 (33.3) | 6 (40.0) | 1 (6.7) | 1 (6.7) | 2 (13.3) | 0 (0.0) |
 Low | 32 (53.3) | 18 (30.0) | 8 (13.3) | 0 (0.0) | 1 (1.7) | 1 (1.7) |
 Moderate | 10 (45.5) | 6 (27.3) | 3 (13.6) | 1 (4.5) | 1 (4.5) | 1 (4.5) |
 High | 0 (0.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
χ 2, P | 14.419, 0.494 | |||||
Growth patterns | ||||||
 Expansive | 1 (50.0) | 1 (50.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
 Invasive | 34 (47.9) | 19 (26.8) | 11 (15.5) | 2 (2.8) | 3 (4.2) | 2 (2.8) |
 Expansive + invasive | 12 (48.0) | 10 (40.0) | 2 (8.0) | 0 (0.0) | 1 (4.0) | 0 (0.0) |
χ 2, P | 5.361, 0.866 | |||||
Metastasis | ||||||
 Yes | 23 (44.2) | 19 (36.5) | 5 (9.6) | 1 (1.9) | 3 (5.8) | 1 (1.9) |
 No | 24 (52.2) | 11 (23.9) | 8 (17.4) | 1 (2.2) | 1 (2.2) | 1 (2.2) |
χ 2, P | 3.558, 0.615 | |||||
Depth of invasion | ||||||
 T1 | 8 (57.1) | 3 (21.4) | 1 (7.1) | 0 (0.0) | 0 (0.0) | 2 (14.3) |
 T2 | 1 (20.0) | 1 (20.0) | 3 (60.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
 T3 | 2 (66.7) | 0 (0.0) | 1 (33.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
 T4 | 36 (47.4) | 26 (34.2) | 8 (10.5) | 2 (2.6) | 4 (5.3) | 0 (0.0) |
χ 2, P | 21.061, 0.135 | |||||
Lymph node metastasis | ||||||
 N0 | 25 (48.1) | 15 (28.8) | 9 (17.3) | 1 (1.9) | 1 (1.9) | 1 (1.9) |
 N1 | 16 (50.0) | 8 (25.0) | 4 (12.5) | 1 (3.1) | 2 (6.3) | 1 (3.1) |
 N2 | 3 (27.3) | 7 (63.6) | 0 (0.0) | 0 (0.0) | 1 (9.1) | 0 (0.0) |
 Undetermined | 3 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
χ 2, P | 15.280, 0.431 | |||||
Distant metastasis | ||||||
 M0 | 42 (48.8) | 23 (26.7) | 13 (15.1) | 2 (2.3) | 4 (4.7) | 2 (2.3) |
 M1 | 5 (41.7) | 7 (58.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
χ 2, P | 8.417, 0.135 | |||||
TNM staging | ||||||
 I | 9 (50.0) | 4 (22.2) | 3 (16.7) | 0 (0.0) | 0 (0.0) | 2 (11.1) |
 IIA-IIC | 16 (55.2) | 6 (20.7) | 6 (20.7) | 0 (0.0) | 1 (3.4) | 0 (0.0) |
 IIIA-IIIC | 17 (43.6) | 13 (33.3) | 4 (10.3) | 2 (5.1) | 3 (7.7) | 0 (0.0) |
 IVA-IVB | 5 (41.7) | 7 (58.3) | 0 (0.0) | 0 (2.6) | 0 (5.3) | 0 (0.0) |
χ 2, P | 23.131, 0.081 |